| HOME >> MEDICINE >> TECHNOLOGY |
3.3.1.7 Market Drivers and Restraints 87
3.3.1.7.1 Market Drivers 87
3.3.1.7.2 Market Restraints 87
3.3.1.8 Market and Technology Trends 87
3.3.1.8.1 Market Trends 87
3.3.1.8.2 Technology Trends 88
3.3.1.8.3 Strategic Recommendations 89
3.3.2 Hepatitis 89
3.3.2.1 Hepatitis B Virus 89
3.3.2.1.1 Hepatitis B Disease Background and Statistics 89
3.3.2.1.2 Instruments and Reagents for Hepatitis B Detection 91
3.3.2.1.3 Method Comparisons 93
3.3.2.1.4 Hepatitis B Market Size 95
3.3.2.1.5 HBV Market Challenges and Strategic Recommendations 96
3.3.2.1.5.1 Market Drivers and Restraints 96
3.3.2.1.5.1.1 Market Drivers 96
3.3.2.1.5.1.2 Market Restraints 97
3.3.2.1.6 Market and Technology Trends 97
3.3.2.1.6.1 Market Trends 97
3.3.2.1.6.2 Technology Trends 97
3.3.2.1.7 Strategic Recommendations 98
3.3.2.2 Hepatitis C Virus (HCV) Testing 99
3.3.2.2.1 Disease Background and Statistics 99
3.3.2.2.2 Instruments and Reagents for Hepatitis C Detection 105
3.3.2.2.3 Method Comparisons for HCV Tests 110
3.3.2.2.4 Hepatitis C Market Size 112
3.3.2.2.4.1 HCV Market Share 113
3.3.2.2.5 HCV Market Challenges and Strategic Recommendations 114
3.3.2.2.5.1 Market Drivers and Restraints 114
3.3.2.2.5.1.1 Market Drivers 114
3.3.2.2.5.2 Market Restraints 115
3.3.2.2.6 Market and Technology Trends 115
3.3.2.2.6.1 Market Trends 115
3.3.2.2.6.2 Technology Trends 116
3.3.2.2.7 Strategic Recommendations 117
3.3.3 Human Papillomavirus (HPV) 117
3.3.3.1 Disease Background and Statistics 117
3.3.3.2 Instruments and Reagents for HPV Detection 121
3.3.3.3 Method Comparison 128
3.3.3.4 HPV Market Size 129
3.3.3.4.1 North American Market 130
3.3.3.4.2 European Market 132
3.3.3.5 Market
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |